Capecitabine-induced multifocal leukoencephalopathy: A report of five cases

A. Videnovic, I. Semenov, R. Chua-Adajar, L. Baddi, D. T. Blumenthal, A. C. Beck, T. Simuni, S. Futterer, W. Gradishar, C. Tellez, J. J. Raizer*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

71 Scopus citations


Capecitabine is used to treat advanced breast and gastrointestinal malignancies. A single case of encephalopathy and three cases of peripheral neuropathy are the only neurotoxicities reported. The authors report five additional cases of capecitabine-induced multifocal leukoencephalopathy.

Original languageEnglish (US)
Pages (from-to)1792-1794
Number of pages3
Issue number11
StatePublished - Dec 2005

ASJC Scopus subject areas

  • Clinical Neurology


Dive into the research topics of 'Capecitabine-induced multifocal leukoencephalopathy: A report of five cases'. Together they form a unique fingerprint.

Cite this